Acute glucose-lowering effects of pre-meal nateglinide versus glipizide in type 2 diabetes

被引：0
|
作者：
Carroll, MF
Riboni, K
Izard, A
Burge, MR
Schade, DS
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
379
引用
收藏
页码：A93 / A93
页数：1
相关论文
共 50 条
  • [21] INFLUENCE OF GLUCOSE-LOWERING STRATEGIES ON FRACTURE RISK IN TYPE 2 DIABETES
    Gusova, A. A.
    Pavlova, M. G.
    Melnitchenko, G. A.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S160 - S161
  • [22] Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
    Kalyani, Rita R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (13): : 1248 - 1260
  • [23] Glucose-lowering therapies in patients with type 2 diabetes and cardiovascular diseases
    Prattichizzo, Francesco
    La Sala, Lucia
    Ryden, Lars
    Marx, Nikolaus
    Ferrini, Marc
    Valensi, Paul
    Ceriello, Antonio
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (2_SUPPL) : 73 - 80
  • [24] Newer Glucose-Lowering Therapies in Older Adults with Type 2 Diabetes
    Bilal, Anika
    Pratley, Richard E.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (02) : 355 - 375
  • [25] The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
    C. J. Currie
    C. D. Poole
    E. A. M. Gale
    Diabetologia, 2009, 52 : 1766 - 1777
  • [26] Impact of glucose-lowering therapies on risk of stroke in type 2 diabetes
    Bonnet, F.
    Scheen, A. J.
    DIABETES & METABOLISM, 2017, 43 (04) : 299 - 313
  • [27] Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes
    Ferrannini, Ele
    DeFronzo, Ralph A.
    EUROPEAN HEART JOURNAL, 2015, 36 (34) : 2288 - U19
  • [28] Effectiveness of glucose-lowering therapy in type 2 diabetes in primary care
    Jacobs, Esther
    Kostev, Karel
    Rathmann, Wolfgang
    DIABETOLOGE, 2019, 15 (02): : 89 - 95
  • [29] Role of bile acids on glucose-lowering by metformin in type 2 diabetes
    Sansome, D. J.
    Veedfald, S.
    Xie, C.
    Bound, M.
    Grivell, J.
    Jones, K. L.
    Horowitz, M.
    Rayner, C. K.
    Wu, T.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S14 - S15
  • [30] The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
    Currie, C. J.
    Poole, C. D.
    Gale, E. A. M.
    DIABETOLOGIA, 2009, 52 (09) : 1766 - 1777
12345